[Congressional Record Volume 151, Number 28 (Thursday, March 10, 2005)]
[Extensions of Remarks]
[Pages E409-E410]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                 TRIBUTE TO CEDARS-SINAI MEDICAL CENTER

                                 ______
                                 

                         HON. HOWARD L. BERMAN

                             of california

                    in the house of representatives

                        Thursday, March 10, 2005

  Mr. BERMAN. Mr. Speaker, I rise to pay tribute to Cedars-Sinai 
Medical Center--one of the premier hospitals in the world--for 
providing the highest quality of health care to hundreds of thousands 
of people, for its innovative medical research and for its dedicated 
work in supporting, housing and developing the Louis Warschaw Prostate 
Cancer Center.
  Cedars is one of the largest non-profit academic medical centers in 
the Western United States. It has more than 1,800 physicians in all 
medical specialties, more than 8,000 employees and 200 volunteers. The 
physicians are leaders in basic and clinical research. They teach over 
245 residents and fellows in 60 graduate medical education programs.
  For the fifth straight two-year period, Cedars-Sinai has been named 
Southern California's gold standard in health care. In National 
Research Corporation's 2004 Healthcare Market Guide survey, Los Angeles 
area residents named Cedars-Sinai the ``Most Preferred Hospital for All 
Health Needs.'' Cedars-Sinai is internationally renowned for its 
diagnostics and treatment capabilities and its broad spectrum of 
programs and breakthroughs in biomedical research and superlative 
medical education. It ranks among the top 10 non-university hospitals 
in the nation for its research activities.
  The Warschaw family, one of Los Angeles' most prominent, turned to 
Cedars-Sinai to establish the Louis Warschaw Prostate Cancer

[[Page E410]]

Center with the mission of advancing the fight against prostate cancer. 
They did this in honor of their beloved husband and father, Louis 
Warschaw, who died from this disease.
  Prostate cancer is the most commonly diagnosed non-skin cancer in the 
United States. One in six American men will develop prostate cancer in 
the course of his lifetime. Each year more than 220,000 men are 
diagnosed with prostate cancer and about 28,000 die from the disease. 
It is the second leading cause of cancer death in men and requires the 
heavy firepower that Cedars-Sinai can muster.
  Patients at Cedars-Sinai Medical Center and the Louis Warschaw 
Prostate Cancer Center receive the best medical care possible and 
access to emerging therapies through its research programs. These 
programs rely on integrated prostate cancer clinical trials and a 
research lab that supports pre-clinical and clinical drug studies. In 
addition to receiving the most technologically advanced care, patients 
take comfort in knowing that experts from a range of disciplines work 
together to optimize their treatment.
  The Louis Warschaw Prostate Cancer Center's medical ontologists and 
urologists are nationally recognized experts in prostate cancer. They 
include: Dr. Stuart Holden, Medical Director for the Center; Dr. David 
B. Agus, Research Director; Dr. Mitchell E. Gross, Assistant Research 
Director and Dr. Christopher Nu, Urologic Surgeon. They collaborate 
with other leading specialists throughout the country, exchanging 
research and clinical insights and have helped the Center earn its 
stellar reputation.
  Cedars-Sinai's multi-faceted team of medical professionals combat the 
threat of cancer by bringing together experts in surgery, radiology, 
radiation therapy, oncology and pathology. The Louis Warschaw Prostate 
Cancer Center, the Samuel Oschin Comprehensive Cancer Institute, the 
Women's Cancer Research Institute, the Maxine Dunitz Neurosurgical 
Institute, the Saul and Joyce Brandman Breast Center, the Gene 
Therapeutics Research Institute, and the divisions of the Medical, 
Surgical, Gynecologic, and Pediatric Oncology, all work together with 
clinical departments across specialties that include medicine, surgery, 
genetics, gynecology, pediatrics, psychiatry, imaging, radiation 
therapy, pathology, and the Cedars-Sinai Outpatient Cancer Center. The 
results of this high level of coordination and cooperation have made 
Cedars-Sinai into the incredible institute it is today. I am proud that 
Cedars is located in Los Angeles and I am thankful for the great work 
it does.
  Mr. Speaker, I ask my distinguished colleagues to join me in saluting 
the Cedars-Sinai Medical Center, and the Warschaw family for founding 
the Louis Warschaw Prostate Cancer Center--one of the Nation's leading 
research and prostate cancer treatment facilities.

                          ____________________